ArticleProstate cancer and prostatic diseases2023

Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer.

Aaron P Mitchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.